AVNS vs RCL · rev $687.8M vs P/E 26, rev $9.28B
Avanos Medical Inc (AVNS) versus Royal Caribbean Cruises Ltd (RCL) — a side-by-side from cached financials, not a winner call.
Avanos Medical Inc (AVNS) is a medical devices company listed on NYSE.
Royal Caribbean Cruises Ltd (RCL) is a travel services company listed on US.
Latest reported AVNS revenue for 2024-12-31 was $687.8M. Net income was -$392.1M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. AVNS currently screens at market cap $1.17B.
Latest reported RCL revenue for 2026-06-30 was $9.28B. Net income was $2.07B. RCL currently screens at market cap $85.57B and trailing P/E 25.7.
AVNS currently screens at market cap $1.17B. RCL currently screens at market cap $85.57B and trailing P/E 25.7.
Not investment advice. Open the AVNS and RCL stock pages for the full models.
Not investment advice.